VTRS Stock Analysis: Buy, Sell, or Hold?
VTRS - Viatris Inc. Common Stock
$13.09
0.02 (0.15%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When VTRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VTRS shows positive signals but monitor for confirmation. Market pricing in 2.6% growth. Moderate conviction.
💡 BUY OPPORTUNITY: VTRS shows positive signals but monitor for confirmation. Market pricing in 2.6% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.03
Based on 5.7% avg growth
INTRINSIC VALUE TODAY
$9.96
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VTRS is currently trading at $13.09, which is considered slightly high relative to its 30-day fair value range of $12.34 to $13.10. The stock's valuation (Forward PE: 5.3) is in line with its historical norms (4.9). At these levels, the market is pricing in 2.6% annual earnings growth.
Technical Outlook: Technically, VTRS is in a strong uptrend. The price is approaching resistance at $13.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VTRS is in a strong uptrend. The price is approaching resistance at $13.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$12.34 -
$13.10
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($13.11)
- BULLISH: Expecting earnings turnaround to 2.6% growth with 0.2% revenue growth
Fair Price Analysis
30-Day Fair Range
$12.34 -
$13.10
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$12.55
Resistance Level
$13.41
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
5.27
Wall Street Target
$13.11
(+0.3%)
Revenue Growth (YoY)
0.2%
Earnings Growth (YoY)
-70.6%
Profit Margin
-26.1%
Valuation Premium vs History
+2.6% premium
PE vs Historical
5.3 vs 4.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.6%
(market-implied from PE analysis)
1-Year Target
$13.41
(+3%)
2-Year Target
$13.76
(+5%)
3-Year Target
$14.12
(+8%)
3-Yr Target (if PE normalizes)
(PE: 5→5)
PE COMPRESSION
$13.13
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 7.4%)
$68.48
(+424%)
Base:
(SPY PE: 5.3, Growth: 7.4%)
$16.18
(+24%)
Bear:
(PE: 4.5, Growth: 7.4%)
$13.75
(+5%)
Last updated: January 31, 2026 5:59 AM ET
Data refreshes hourly during market hours. Next update: 6:59 AM
Data refreshes hourly during market hours. Next update: 6:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTRS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Goff Corinne Le
SELL
7032 shares
2025-09-11
Scott Andrew Smith
BUY
22000 shares
2025-08-12
Featured in Portfolios
VTRS is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced VTRS Option Strategies
Professional options setups generated by AI based on today's VTRS price and gamma walls.
